202 related articles for article (PubMed ID: 9151680)
1. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.
Yu W; Kim J; Ossowski L
J Cell Biol; 1997 May; 137(3):767-77. PubMed ID: 9151680
[TBL] [Abstract][Full Text] [Related]
2. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
Kook YH; Adamski J; Zelent A; Ossowski L
EMBO J; 1994 Sep; 13(17):3983-91. PubMed ID: 8076594
[TBL] [Abstract][Full Text] [Related]
3. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
Aguirre Ghiso JA; Kovalski K; Ossowski L
J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
[TBL] [Abstract][Full Text] [Related]
5. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
Mohanam S; Chintala SK; Mohan PM; Sawaya R; Lagos GK; Gokaslan ZL; Kouraklis GP; Rao JS
Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
Aguirre Ghiso JA
Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
[TBL] [Abstract][Full Text] [Related]
9. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
Ahmed N; Oliva K; Wang Y; Quinn M; Rice G
Br J Cancer; 2003 Jul; 89(2):374-84. PubMed ID: 12865932
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
12. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.
Ossowski L; Clunie G; Masucci MT; Blasi F
J Cell Biol; 1991 Nov; 115(4):1107-12. PubMed ID: 1659573
[TBL] [Abstract][Full Text] [Related]
13. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
14. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
15. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.
Aguirre-Ghiso JA; Liu D; Mignatti A; Kovalski K; Ossowski L
Mol Biol Cell; 2001 Apr; 12(4):863-79. PubMed ID: 11294892
[TBL] [Abstract][Full Text] [Related]
16. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
17. [Antisense RNA for urokinase receptor inhibits the invasiveness and metastasis of lung carcinoma].
Liao J; Xu S; Tang H; Lian F; Zhu Y
Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):357-60. PubMed ID: 11769733
[TBL] [Abstract][Full Text] [Related]
18. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
19. The role of plasminogen activator receptor in cancer invasion and dormancy.
Ossowski L; Aguirre Ghiso J; Liu D; Yu W; Kovalski K
Medicina (B Aires); 1999; 59(5 Pt 2):547-52. PubMed ID: 10684157
[TBL] [Abstract][Full Text] [Related]
20. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
